Prostate Cancer UK awards a range of research grants with the support of our partners, the Movember Foundation. We fund scientists at different stages of their careers as they research important topics covering various stages of the prostate cancer journey. You can see some video examples of the research we fund below, or read more about all of our grants.

Professor Craig Robson

Professor Craig Robson’s lab is interested in the molecular biology, otherwise known as the nuts and bolts, of prostate cancer.

His lab members hold four Movember Foundation funded Prostate Cancer UK grants between them, each covering a different stage of a scientist’s career, from PhD student (James) to established scientist (Craig), via newly independent researcher (Kelly) and clinician scientist (Alice). This film will tell you a bit about the work in their lab, and what it takes to be a Prostate Cancer UK scientist:

Dr Claire Wells

Prostate Cancer UK PhD studentships are awarded to train the next generation of prostate cancer researchers. The video below shows Mario de Piano, a Movember Foundation funded PhD student in Dr Claire Wells lab, tackling how and why cancer cells spread – and whether they use fat as an energy source:

Dr Christine Galustian

Dr Christine Galustian has been awarded two Prostate Cancer UK Pilot Awards in the last few years, funded by The Movember Foundation. These awards are intended to open up new, exciting and unexplored avenues of research – which can then go on to achieve big results. Christine’s first award was to look at how white blood cells interact with cancer; an approach that could help the immune system destroy the tumor. Her second grant is to investigate whether loss of a particular protein increases the risk of prostate cancer in African-Caribbean men:

Professor Alan Clarke

Dr Valerie Meniel and Dr Matthew Jeffries work in Professor Alan Clarke’s lab at Cardiff University. They’re working on a Prostate Cancer UK project grant, funded by The Movember Foundation that focuses on the genes involved in the very first steps of cancer development: